Home
Conditions
Pituitary Diseases

Clinical trial condition

Pituitary Diseases

Explore clinical trials studying Pituitary Diseases. Study availability and eligibility vary by location and protocol.

673 public trials 95 recruiting studies

Refine in advanced search Browse all conditions

Pituitary Diseases trial results

Completed

Canadian Pegvisomant Compassionate Study In Acromegalic Patients

NCT00151437

Conditions: Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations: Pfizer Investigational Site Edmonton, Alberta, Canada

Pfizer Investigational Site Edmonton, Alberta, Canada

Pfizer Investigational Site Halifax, Nova Scotia, Canada

Pfizer Investigational Site Toronto, Ontario, Canada

View Trial Details

Completed

Cardiac Valve Complications in Prolactinomas Treated With Cabergoline

NCT00460616

Conditions: Adenoma, Brain Diseases, Cardiovascular Diseases, +15 more
Locations: Department of Molecular and Clinical Endocrinology and Oncology, University Federico II of Naples Via S. Pansini 5 Naples, Italy

View Trial Details

Completed

A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly

NCT00068042

Conditions: Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations: Pfizer Investigational Site Los Angeles, California, United States

Pfizer Investigational Site Chicago, Illinois, United States

Pfizer Investigational Site Chicago, Illinois, United States

Pfizer Investigational Site Boston, Massachusetts, United States

View all 55 locations

View Trial Details

Completed

Pegvisomant And Sandostatin LAR Combination Study

NCT00068029

Conditions: Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations: Pfizer Investigational Site Los Angeles, California, United States

Pfizer Investigational Site Boston, Massachusetts, United States

Pfizer Investigational Site Chapel Hill, North Carolina, United States

Pfizer Investigational Site Charlottesville, Virginia, United States

View all 33 locations

View Trial Details

Completed

Acute Application of Pegvisomant and Octreotide in Acromegaly

NCT00595140

Conditions: Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations: Medizinische Klinik - Innenstadt of the University of Munich Munich, Germany

View Trial Details

Completed

Replacement GH Therapy After Bariatric Surgery in Patients With Very Severe Obesity

NCT00553852

Conditions: Body Weight, Bone Diseases, Bone Diseases, Developmental, +19 more
Locations: Department of Molecular and Clinical Endocrinology and Oncology Federico II University Naples, Italy

View Trial Details

Completed

Change in Quality of Life After Addition of Weekly 40 mg Pegvisomant/Placebo in Controlled Acromegalic Patients

NCT00642720

Conditions: Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +9 more
Locations: Not specified

View Trial Details

Completed

A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome

NCT00017927

Conditions: Acromegaly, Adenoma, Bone Diseases, +21 more
Locations: National Institute of Dental And Craniofacial Research (NIDCR) Bethesda, Maryland, United States

View Trial Details

Completed

Evaluation of Factors in Human Brain Tumors

NCT00001171

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasm, +23 more
Locations: National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States

View Trial Details

Completed

Sandostatin LAR Depot vs. Surgery for Treating Acromegaly

NCT00001860

Conditions: Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +18 more
Locations: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States

View Trial Details

Pituitary Diseases

Pituitary Diseases trial results

Related conditions